MedPage Today November 23, 2019
David Nash, MD, MBA, FACP

-Observers are divided on whether these deals are good for healthcare

Several months ago, I wrote in this space about an “odd couple” on the health care scene — private equity and medical practice.

Although this phenomenon is just beginning to fly above the radar in terms of media coverage, its eventual effect on the healthcare delivery business model and clinical quality outcomes may be profound.

Private equity buyouts began with specialty practice niches such as ophthalmology and dentistry; my previous column was triggered by news that they had spread to primary care/multispecialty practices with the goal of profiting from risk contracts under which they would manage care for Medicare Advantage and Medicaid patients.

Now, the trend seems to be...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Physician, Provider, Trends
New AI drug discovery powerhouse Xaira rises with $1B in funding
Women's virtual care clinic Midi Health raises $60M
AI-enabled drug discovery company Xaira launches with $1B
Claims operation AI company Alaffia Health raises $10M in series A round
Dear venture capitalists: You're blowing it

Share This Article